Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 15/20 | 0.83 |
| ▸ | IKZF3 | Q9UKT9 | 15/20 | 0.83 |
| ▸ | TNF | P01375 | 6/20 | 0.73 |
| ▸ | IL1B | P01584 | 3/20 | 0.73 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.73 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30080313 | 1.00 | CRBN (0.83) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL22252476 | 0.94 | CRBN (0.74) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL24288801 | 0.92 | CRBN (0.83) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL2254415 | 0.92 | CRBN (0.83) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL12358821 | 0.91 | CRBN (0.85) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL20766654 | 0.91 | CRBN (0.85) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL17724114 | 0.91 | CRBN (0.85) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL12445788 | 0.91 | CRBN (0.85) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL17724118 | 0.91 | CRBN (0.85) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL10208068 | 0.91 | CRBN (1.00) | CRBNIKZF3TNFIL1BIKZF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4289838-A2 | ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | Celgene Corporation (US) | 2023-12-13 | — | — | EP | disclosed |
| EP-3599236-B1 | ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | CELGENE CORP (US) | 2023-08-23 | — | — | EP | disclosed |
| EP-3599236-A1 | ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | Celgene Corporation (US) | 2020-01-29 | — | — | EP | disclosed |
| EP-3202460-B1 | ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | CELGENE CORP (US) | 2019-06-12 | — | — | EP | disclosed |
| EP-3106460-B1 | ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | CELGENE CORP (US) | 2019-04-10 | — | — | EP | disclosed |
| EP-3202461-A1 | ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | Celgene Corporation (US) | 2017-08-09 | — | — | EP | disclosed |
| EP-3202460-A1 | ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | Celgene Corporation (US) | 2017-08-09 | — | — | EP | disclosed |
| EP-2536706-B1 | ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | CELGENE CORP (US) | 2017-06-14 | — | — | EP | disclosed |